<?xml version="1.0" encoding="UTF-8"?>
<p>Standard uniform prophylaxis has been applied for all patients undergoing HCT.
 <xref rid="CIT0008" ref-type="bibr">8</xref>,
 <xref rid="CIT0009" ref-type="bibr">9</xref>,
 <xref rid="CIT0011" ref-type="bibr">11</xref> Commonly accepted strategies were performed for prophylactic, empirical and targeted anti-infectious therapy with various agents.
 <xref rid="CIT0008" ref-type="bibr">8</xref>,
 <xref rid="CIT0009" ref-type="bibr">9</xref>,
 <xref rid="CIT0011" ref-type="bibr">11</xref>,
 <xref rid="CIT0012" ref-type="bibr">12</xref> In the case of significant CMV-DNA-emia and EBV-DNA-emia and/or CMV- or EBV-disease, specific treatment was implemented.
</p>
